Several high-yielding dividend stocks recently raised their payouts again. With more dividend growth likely, this trio are great stocks to buy and hold for a steadily rising stream of passive income.

Worried about the next round of tariffs? Tech disruption from DeepSeek? The geopolitical landscape? Then these low-beta dividend stocks could be the answer.

AbbVie is a resurging Dividend King. Amgen's recent clinical setback makes its stock available at a discount. Gilead Sciences is a steady dividend payer with a growing payout. For a while, though, AbbVie might not have been viewed as a fabulous pick by many investors.